Ryan White, a young boy from Kokomo, became a national symbol in the fight against AIDS-related discrimination after being ...

Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United States.

The gene therapy BBM-H901 (dalnacogene ponparvovec) has been approved in China for adults with moderate to severe hemophilia ...

Despite the challenges, including what CSL CEO Paul McKenzie has described as a fragmented U.S. healthcare system, the blood product specialist remains hopeful that Hemgenix is here to stay. “I hope ...

New treatments for Prader-Willi Syndrome and hemophilia; FDA fast tracks a chlamydia vaccine candidate; over-the-counter test cleared for identifying chlamydia, gonorrhea and trichomoniasis.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

H901, has been officially approved by the National Medical Products Administration for the treatment of adult patients with moderate to severe hemophilia B.

Belief BioMed and Takeda China today jointly announced that BBM-H901, has been officially approved by the National Medical ...

This innovative injection was developed and produced by Belief BioMed, while Takeda China is responsible for its ...

More than 40% of the 225 scientists and public health workers at the CDC's National Center on Birth Defects and Developmental ...

To my surprise — and like reviewers who call the tool the best $10 they’ve ever spent — the Bug Bite Thing lived up to the ...